X

Xenon Pharmaceuticals
D

XENE

33.250
USD
-0.13
(-0.39%)
مغلق
حجم التداول
22,031
الربح لكل سهم
-4
العائد الربحي
-
P/E
-10
حجم السوق
2,551,392,167
أصول ذات صلة
A
AKRO
-0.125
(-0.24%)
51.760 USD
AMGN
AMGN
1.79
(0.60%)
298.52 USD
A
ARCT
0.160
(1.18%)
13.770 USD
BIIB
BIIB
-1.170
(-0.88%)
132.000 USD
F
FULC
0.00000
(0.00%)
6.92000 USD
GOOGL
GOOGL
0.720
(0.40%)
179.350 USD
المزيد
الأخبار المقالات

العنوان: Xenon Pharmaceuticals

القطاع: Healthcare
الصناعة: Biotechnology
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.